Issuance of Stock Acquisition Rights for Directors, Employees and Others
First written in FY2017-Q2. 16 of 26 entries say "Dropped", first in FY2017-Q3. Latest entry: FY2025-Q1.
- FY2025-Q1DroppedAnnual report
「Not applicable.」
States that there were no applicable matters involving the issuance of stock options during the current first-quarter accounting period. The Sixth Series Stock Acquisition Rights issued through a third-party allotment are addressed separately. - FY2024Updated the exercise and outstanding status of existing stock acquisition rightsAnnual report
「Exercised 9,600 11,200 11,200 12,000 7,200 Unexercised balance 6,800 10,000 10,800 12,000 12,000」
For the First through Fifth Series Stock Acquisition Rights, a total of 51,200 shares were exercised during the fiscal year, and the unexercised balance for each series was updated. This was not a new stock option issuance for officers and employees. - FY2024-Q3DroppedAnnual report
「Not applicable.」
States that there were no applicable matters involving the issuance of stock acquisition rights during the third-quarter accounting period. - FY2024-Q2DroppedAnnual report
「Not applicable.」
States that there were no applicable matters involving the issuance of stock acquisition rights during the second-quarter accounting period. - FY2024-Q1DroppedAnnual report
「Not applicable.」
States that there were no applicable matters involving the issuance of stock acquisition rights during the current first-quarter accounting period. - FY2023Updated the exercise and outstanding status of stock acquisition rightsAnnual report
「Disposal of treasury shares 42,000」
Records the disposal of 42,000 treasury shares through the exercise of stock acquisition rights. It also records the unexercised balance for each series of stock acquisition rights, indicating an update to the exercise and outstanding status of the existing scheme rather than a new issuance. - FY2023-Q3DroppedAnnual report
「Not applicable.」
States that there were no applicable matters involving the issuance of stock acquisition rights during the third-quarter accounting period. - FY2023-Q2DroppedAnnual report
「Not applicable.」
States that there were no applicable matters involving the issuance of stock acquisition rights during the current second-quarter accounting period. - FY2023-Q1DroppedAnnual report
「Not applicable.」
States that there were no applicable matters involving the issuance of stock acquisition rights during the current first-quarter accounting period. - FY2022-Q3DroppedAnnual report
「Not applicable.」
States that there were no applicable matters involving the issuance of stock acquisition rights during the current third-quarter accounting period. - FY2021-Q3DroppedAnnual report
「Not applicable.」
States that there were no applicable matters involving the issuance of stock acquisition rights during the current third-quarter accounting period. - FY2021-Q2RestatedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
Reconfirms the details of the Fifth Series Stock Acquisition Rights resolved on 15 May 2020: 48 rights covering 4,800 common shares for 3 directors, with an exercise period from 2 June 2020 to 1 June 2070. - FY2021-Q1DroppedAnnual report
「Not applicable.」
States that there were no applicable matters involving the issuance of stock acquisition rights during the current first-quarter accounting period. - FY2020AdvancedAnnual report
「Fifth Series Stock Acquisition Rights Resolution date 15 May 2020 Eligible recipients and number of recipients (people) Directors of the Company 3 Number of stock acquisition rights (rights) 48 Class, terms and number of underlying shares (shares) Common shares 4,800 Exercise period From 2 June 2020 to 1 June 2070」
Added the issuance details for the Fifth Series Stock Acquisition Rights: 48 rights covering 4,800 common shares, granted to 3 directors. - FY2020-Q3DroppedAnnual report
「Not applicable.」
States that there were no applicable matters involving the issuance of stock acquisition rights during the current third-quarter accounting period. - FY2020-Q2RestatedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
Reconfirms the details of the Fourth Series Stock Acquisition Rights resolved on 17 May 2019: 86 rights covering 8,600 common shares for 4 directors, with an exercise period from 4 June 2019 to 3 June 2069. - FY2020-Q1DroppedAnnual report
「Not applicable.」
States that there were no applicable matters involving the issuance of stock acquisition rights during the current first-quarter accounting period. - FY2019AdvancedAnnual report
「Fourth Series Stock Acquisition Rights Resolution date 17 May 2019 Eligible recipients and number of recipients (people) Directors of the Company 4 Number of stock acquisition rights (rights) 86 Class, terms and number of underlying shares (shares) Common shares 8,600 Exercise period From 4 June 2019 to 3 June 2069」
Records the issuance details for the Fourth Series Stock Acquisition Rights: 86 rights covering 8,600 common shares, granted to 4 directors. - FY2019-Q3DroppedAnnual report
「Not applicable.」
States that there were no applicable matters involving the issuance of stock acquisition rights during the third-quarter accounting period. - FY2019-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
Records the issuance details resolved on 17 May 2018: 79 stock acquisition rights, 7,900 underlying shares, and an exercise period from 2 June 2018 to 1 June 2068. - FY2019-Q1DroppedAnnual report
「Not applicable.」
States that there were no applicable matters involving the issuance of stock acquisition rights during the current first-quarter accounting period. - FY2018-Q3DroppedAnnual report
「Not applicable.」
States that there were no applicable matters involving the issuance of stock acquisition rights during the current third-quarter accounting period. - FY2018-Q2RestatedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
Restates the issuance details for the Second Series Stock Acquisition Rights: 91 rights, 9,100 underlying shares, and an exercise period from 2 June 2017 to 1 June 2037. - FY2017AdvancedAnnual report
「Second Series Stock Acquisition Rights (resolved at the Board of Directors meeting held on 17 May 2017)」
In addition to the 7,700 shares under the previously issued First Series Stock Acquisition Rights, the issuance details for the Second Series Stock Acquisition Rights, targeted at 4 directors and 4 executive officers, cover 9,100 shares, with an exercise period from 2 June 2017 to 1 June 2037. - FY2017-Q3DroppedAnnual report
「Not applicable.」
No applicable matters were reported regarding stock acquisition rights and other instruments for the third quarter, and no issuance of stock acquisition rights for directors, employees or others, which was reported in the previous quarter, has been identified this time. - FY2017-Q2First statedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
For the resolution dated 17 May 2016, the company issued 77 stock acquisition rights representing 7,700 shares. The exercise period runs from 2 June 2016 to 1 June 2078. The issue price was ¥3,734 and the amount credited to capital was ¥1,867. The rights were granted to directors, advisers, executive officers, employees and others.